{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:36:25Z","timestamp":1790044585202,"version":"4.0.1"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10709-7","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T12:07:35Z","timestamp":1750507655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mechanistic insight into nanomedicine for polycystic ovary syndrome"],"prefix":"10.1007","volume":"52","author":[{"given":"Maisra Azhar","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan S","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubin Mustafa","family":"Kiyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"6","key":"10709_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/ijamh-2021-0031","volume":"33","author":"M Zehravi","year":"2021","unstructured":"Zehravi M, Maqbool M, Ara I (2021) Polycystic ovary syndrome and reproductive health of women: a curious association. Int J Adolesc Med Health 33(6):333\u2013337","journal-title":"Int J Adolesc Med Health"},{"issue":"6","key":"10709_CR2","first-page":"875","volume":"7","author":"B Zehra","year":"2018","unstructured":"Zehra B, Khursheed A (2018) Polycystic ovarian syndrome: symptoms, treatment and diagnosis: a review. J Pharmacognosy Phytochemistry 7(6):875\u2013880","journal-title":"J Pharmacognosy Phytochemistry"},{"issue":"3","key":"10709_CR3","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T (2021) Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metabolism 106(3):e1071\u2013e83","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"10709_CR4","first-page":"1","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS et al (2016) Polycystic ovary syndrome. Nat Reviews Disease Primers 2(1):1\u201318","journal-title":"Nat Reviews Disease Primers"},{"issue":"4","key":"10709_CR5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.rbmo.2010.04.032","volume":"21","author":"M Guo","year":"2010","unstructured":"Guo M, Chen Z, Macklon N, Shi Y, Westerveld H, Eijkemans M et al (2010) Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria. Reprod Biomed Online 21(4):572\u2013580","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10709_CR6","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.fertnstert.2014.01.049","volume":"101","author":"JJ Kim","year":"2014","unstructured":"Kim JJ, Hwang KR, Choi YM, Moon SY, Chae SJ, Park CW et al (2014) Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome. Fertil Steril 101(5):1424\u20131430 e3","journal-title":"Fertil Steril"},{"issue":"6","key":"10709_CR7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/den090","volume":"23","author":"L Cheung","year":"2008","unstructured":"Cheung L, Ma R, Lam P, Lok I, Haines C, So W et al (2008) Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod 23(6):1431\u20131438","journal-title":"Hum Reprod"},{"key":"10709_CR8","doi-asserted-by":"crossref","unstructured":"Zulfiqar S, Tahir S, Gulraiz S, Razzaq MA, Abid A, Shahid T et al (2022) Investigation of prevalence and awareness of polycystic ovary syndrome among Pakistani females: polycystic ovary syndrome in Pakistani women. Proceedings of the Pakistan Academy of Sciences: B Life and Environmental Sciences 59(1):77\u201383","DOI":"10.53560\/PPASB(59-1)703"},{"issue":"1","key":"10709_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/GRF.0000000000000596","volume":"64","author":"K Walker","year":"2021","unstructured":"Walker K, Decherney AH, Saunders R (2021) Menstrual dysfunction in PCOS. Clin Obstet Gynecol 64(1):119\u2013125","journal-title":"Clin Obstet Gynecol"},{"issue":"8","key":"10709_CR10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS (2019) Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 3(8):1545\u20131573","journal-title":"J Endocr Soc"},{"issue":"6","key":"10709_CR11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/jcm9061831","volume":"9","author":"E Khashchenko","year":"2020","unstructured":"Khashchenko E, Uvarova E, Vysokikh M, Ivanets T, Krechetova L, Tarasova N et al (2020) The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents. J Clin Med 9(6):1831","journal-title":"J Clin Med"},{"issue":"1","key":"10709_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.advms.2021.12.003","volume":"67","author":"F Mahboobifard","year":"2022","unstructured":"Mahboobifard F, Rahmati M, Amiri M, Azizi F, Tehrani FR (2022) To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study. Adv Med Sci 67(1):79\u201386","journal-title":"Adv Med Sci"},{"issue":"4","key":"10709_CR13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1530\/EC-20-0080","volume":"9","author":"F Schederecker","year":"2020","unstructured":"Schederecker F, Cecil A, Prehn C, Nano J, Koenig W, Adamski J et al (2020) Sex hormone-binding globulin, androgens and mortality: the KORA-F4 cohort study. Endocr Connections 9(4):326\u2013336","journal-title":"Endocr Connections"},{"key":"10709_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2019.09.010","volume":"499","author":"J-l Zhu","year":"2019","unstructured":"Zhu J-l, Chen Z, Feng W-j (2019) Long S-l, mo Z-C. Sex hormone-binding Globulin and polycystic ovary syndrome. Clin Chim Acta 499:142\u2013148","journal-title":"Clin Chim Acta"},{"key":"10709_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","volume":"130","author":"D Macut","year":"2017","unstructured":"Macut D, Bjeki\u0107-Macut J, Raheli\u0107 D, Dokni\u0107 M (2017) Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract 130:163\u2013170","journal-title":"Diabetes Res Clin Pract"},{"key":"10709_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie Y-j, Liu Y-t, Long S-l (2020) Mo Z-c. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta 502:214\u2013221","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10709_CR17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cen.13808","volume":"89","author":"S Shorakae","year":"2018","unstructured":"Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, de Courten B et al (2018) Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol 89(5):628\u2013633","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10709_CR18","first-page":"132","volume":"30","author":"R Jabbar","year":"2019","unstructured":"Jabbar R, Kanwal Z, Farooq S, Zia A, Amir S, Naz S (2019) Study of insulin resistance and glucose transporter protein 4 in polycystic ovarian syndrome. Natl Editorial Advisory Board 30(10):132","journal-title":"Natl Editorial Advisory Board"},{"issue":"10","key":"10709_CR19","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1210\/clinem\/dgaa425","volume":"105","author":"Y Shang","year":"2020","unstructured":"Shang Y, Zhou H, Hu M, Feng H (2020) Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metabolism 105(10):3346\u20133360","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"12","key":"10709_CR20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/diab.45.12.1661","volume":"45","author":"AR Saltiel","year":"1996","unstructured":"Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45(12):1661\u20131669","journal-title":"Diabetes"},{"issue":"1","key":"10709_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","volume":"13","author":"S Livadas","year":"2022","unstructured":"Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R (2022) Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review. World J Diabetes 13(1):5","journal-title":"World J Diabetes"},{"issue":"1","key":"10709_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-021-00933-7","volume":"15","author":"J Zou","year":"2022","unstructured":"Zou J, Li Y, Liao N, Liu J, Zhang Q, Luo M et al (2022) Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis. J Ovarian Res 15(1):1\u201316","journal-title":"J Ovarian Res"},{"issue":"8","key":"10709_CR23","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C (2022) Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci 23(8):4110","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10709_CR24","first-page":"165","volume":"10","author":"L Cassidy-Vu","year":"2016","unstructured":"Cassidy-Vu L, Joe E, Kirk JK (2016) Role of Statin drugs for polycystic ovary syndrome. J Family Reproductive Health 10(4):165","journal-title":"J Family Reproductive Health"},{"issue":"4","key":"10709_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/09513590.2012.754876","volume":"29","author":"R Paradisi","year":"2013","unstructured":"Paradisi R, Fabbri R, Battaglia C, Venturoli S (2013) Ovulatory effects of Flutamide in the polycystic ovary syndrome. Gynecol Endocrinol 29(4):391\u2013395","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10709_CR26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cen.12468","volume":"81","author":"K Aydin","year":"2014","unstructured":"Aydin K, Arusoglu G, Koksal G, Cinar N, Yazgan Aksoy D, Yildiz BO (2014) Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome. Clin Endocrinol 81(4):588\u2013592","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10709_CR27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ph14010042","volume":"14","author":"AO Shpakov","year":"2021","unstructured":"Shpakov AO (2021) Improvement effect of Metformin on female and male reproduction in endocrine pathologies and its mechanisms. Pharmaceuticals 14(1):42","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10709_CR28","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-15-0447","volume":"228","author":"H An","year":"2016","unstructured":"An H, He L (2016) Current Understanding of Metformin effect on the control of hyperglycemia in diabetes. J Endocrinol 228(3):R97","journal-title":"J Endocrinol"},{"issue":"8","key":"10709_CR29","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.18203\/2320-1770.ijrcog20173470","volume":"6","author":"BV Sontakke","year":"2017","unstructured":"Sontakke BV (2017) PCOS in adolescence: effect of Metformin on menstrual irregularities. Int J Reprod Contracept Obstet Gynecol 6(8):3490\u20133498","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"11","key":"10709_CR30","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4066\/biomedicalresearch.40-18-526","volume":"29","author":"M Fatima","year":"2018","unstructured":"Fatima M, Sadeeqa S, Nazir SUR (2018) Metformin and its Gastrointestinal problems: A review. Biomed Res 29(11):2285\u20132289","journal-title":"Biomed Res"},{"issue":"11","key":"10709_CR31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jdv.12116","volume":"27","author":"D Badr","year":"2013","unstructured":"Badr D, Kurban M, Abbas O (2013) Metformin in dermatology: an overview. J Eur Acad Dermatol Venereol 27(11):1329\u20131335","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10709_CR32","doi-asserted-by":"crossref","unstructured":"Sher EK, Alebi\u0107 M, Boras MM, Bo\u0161kailo E, Farhat EK, Karahmet A et al (2024) Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments. Int J Pharm.:124345","DOI":"10.1016\/j.ijpharm.2024.124345"},{"issue":"6","key":"10709_CR33","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/acsnano.7b01493","volume":"11","author":"MM Alvarez","year":"2017","unstructured":"Alvarez MM, Aizenberg J, Analoui M, Andrews AM, Bisker G, Boyden ES et al (2017) Emerging trends in micro-and nanoscale technologies in medicine: from basic discoveries to translation. ACS Nano 11(6):5195\u20135214","journal-title":"ACS Nano"},{"key":"10709_CR34","doi-asserted-by":"crossref","unstructured":"Barenholz YC (2021) Doxil\u00ae\u2014The first FDA-approved nano-drug: From an idea to a product. Handbook of harnessing biomaterials in nanomedicine. Jenny Stanford Publishing, pp 463\u2013528","DOI":"10.1201\/9781003125259-16"},{"issue":"9","key":"10709_CR35","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/17425247.2020.1783237","volume":"17","author":"M Mukhtar","year":"2020","unstructured":"Mukhtar M, Ali H, Ahmed N, Munir R, Talib S, Khan AS et al (2020) Drug delivery to macrophages: A review of nano-therapeutics targeted approach for inflammatory disorders and cancer. Expert Opin Drug Deliv 17(9):1239\u20131257","journal-title":"Expert Opin Drug Deliv"},{"key":"10709_CR36","doi-asserted-by":"crossref","unstructured":"Rehman MU, Khan A, Imtiyaz Z, Ali S, Makeen HA, Rashid S et al (eds) (2022) Current nano-therapeutic approaches ameliorating inflammation in cancer progression. Seminars in cancer biology. Elsevier","DOI":"10.1016\/j.semcancer.2022.02.006"},{"issue":"13","key":"10709_CR37","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1039\/D2RA07863E","volume":"13","author":"MJ Nirmala","year":"2023","unstructured":"Nirmala MJ, Kizhuveetil U, Johnson A, Balaji G, Nagarajan R, Muthuvijayan V (2023) Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv 13(13):8606\u20138629","journal-title":"RSC Adv"},{"issue":"4","key":"10709_CR38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","volume":"16","author":"AR Kirtane","year":"2021","unstructured":"Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G (2021) Nanotechnology approaches for global infectious diseases. Nat Nanotechnol 16(4):369\u2013384","journal-title":"Nat Nanotechnol"},{"key":"10709_CR39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.25258\/ijddt.9.1.16","volume":"9","author":"A Suttee","year":"2019","unstructured":"Suttee A, Singh G, Yadav N, Pratap Barnwal R, Singla N, Prabhu KS et al (2019) A review on status of nanotechnology in pharmaceutical sciences. Int J Drug Deliv Technol 9:98\u2013103","journal-title":"Int J Drug Deliv Technol"},{"key":"10709_CR40","doi-asserted-by":"crossref","unstructured":"Dwyer AA, Quinton R (2019) Anatomy and physiology of the hypothalamic-pituitary-gonadal (HPG) axis. Advanced Practice in Endocrinology Nursing 839\u2013\u200952","DOI":"10.1007\/978-3-319-99817-6_43"},{"key":"10709_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-018-0366-6","volume":"16","author":"M Goldsammler","year":"2018","unstructured":"Goldsammler M, Merhi Z, Buyuk E (2018) Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. Reproductive Biology Endocrinol 16:1\u201310","journal-title":"Reproductive Biology Endocrinol"},{"key":"10709_CR42","doi-asserted-by":"crossref","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M (2019) Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci 236:116940","journal-title":"Life Sci"},{"key":"10709_CR43","doi-asserted-by":"crossref","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W et al (2021) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol 12:741764","journal-title":"Front Endocrinol"},{"key":"10709_CR44","doi-asserted-by":"crossref","unstructured":"Xu Y, Qiao J (2022) Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. Journal of healthcare engineering. 2022","DOI":"10.1155\/2022\/9240569"},{"issue":"5","key":"10709_CR45","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/ani10050915","volume":"10","author":"EM Waszkiewicz","year":"2020","unstructured":"Waszkiewicz EM, Kozlowska W, Zmijewska A, Franczak A (2020) Expression of insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) receptors and the effect of IGF-1 and EGF on androgen and Estrogen release in the myometrium of pigs\u2014In vitro study. Animals 10(5):915","journal-title":"Animals"},{"key":"10709_CR46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fendo.2019.00777","volume":"10","author":"E Ipsa","year":"2019","unstructured":"Ipsa E, Cruzat VF, Kagize JN, Yovich JL, Keane KN (2019) Growth hormone and insulin-like growth factor action in reproductive tissues. Front Endocrinol 10:777","journal-title":"Front Endocrinol"},{"key":"10709_CR47","doi-asserted-by":"crossref","unstructured":"Basualto-Alarc\u00f3n C, Llanos P, Garc\u00eda-Rivas G, Troncoso MF, Lagos D, Barrientos G et al (2021) Classic and novel sex hormone binding globulin effects on the cardiovascular system in men. International Journal of Endocrinology. 2021","DOI":"10.1155\/2021\/5527973"},{"key":"10709_CR48","doi-asserted-by":"crossref","unstructured":"Chaudhuri A (2023) Polycystic ovary syndrome: causes, symptoms, pathophysiology, and remedies. Obes Med.:100480","DOI":"10.1016\/j.obmed.2023.100480"},{"key":"10709_CR49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40618-018-0949-2","volume":"42","author":"L Mu","year":"2019","unstructured":"Mu L, Li R, Lai Y, Zhao Y, Qiao J (2019) Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome. J Endocrinol Investig 42:541\u2013548","journal-title":"J Endocrinol Investig"},{"issue":"7","key":"10709_CR50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","volume":"30","author":"O Osibogun","year":"2020","unstructured":"Osibogun O, Ogunmoroti O, Michos ED (2020) Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med 30(7):399\u2013404","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10709_CR51","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/en.2019-00101","volume":"160","author":"O Astapova","year":"2019","unstructured":"Astapova O, Minor BM, Hammes SR (2019) Physiological and pathological androgen actions in the ovary. Endocrinology 160(5):1166\u20131174","journal-title":"Endocrinology"},{"issue":"1","key":"10709_CR52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13048-022-01062-5","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhong Y, Shen X, Guo X, Wu R, Yang T et al (2022) Luteinizing hormone stimulates the expression of Amphiregulin in human theca cells. J Ovarian Res 15(1):129","journal-title":"J Ovarian Res"},{"key":"10709_CR53","doi-asserted-by":"crossref","first-page":"106216","DOI":"10.1016\/j.jsbmb.2022.106216","volume":"226","author":"M Chen","year":"2023","unstructured":"Chen M, Guo X, Zhong Y, Liu Y, Cai B, Wu R et al (2023) AMH inhibits androgen production in human theca cells. J Steroid Biochem Mol Biol 226:106216","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"10709_CR54","doi-asserted-by":"crossref","first-page":"103369","DOI":"10.1016\/j.rbmo.2023.103369","volume":"47","author":"A La Marca","year":"2023","unstructured":"La Marca A, Longo M, Sighinolfi G, Grisendi V, Imbrogno MG, Giulini S (2023) New insights into the role of LH in early ovarian follicular growth: a possible tool to optimize follicular recruitment. Reprod Biomed Online 47(6):103369","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10709_CR55","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/jcm9041014","volume":"9","author":"D Santi","year":"2020","unstructured":"Santi D, Cr\u00e9pieux P, Reiter E, Spaggiari G, Brigante G, Casarini L et al (2020) Follicle-stimulating hormone (FSH) action on spermatogenesis: a focus on physiological and therapeutic roles. J Clin Med 9(4):1014","journal-title":"J Clin Med"},{"issue":"2","key":"10709_CR56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/rda.13837","volume":"56","author":"H Duan","year":"2021","unstructured":"Duan H, Xiao L, Ge W, Yang S, Jiang Y, Lv J et al (2021) Follicle-stimulating hormone and luteinizing hormone regulate the synthesis mechanism of dihydrotestosterone in sheep granulosa cells. Reprod Domest Anim 56(2):292\u2013300","journal-title":"Reprod Domest Anim"},{"issue":"7","key":"10709_CR57","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","volume":"90","author":"S Palomba","year":"2005","unstructured":"Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and Metformin as the first-line treatment for ovulation induction in Nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metabolism 90(7):4068\u20134074","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"10709_CR58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0974-1208.97789","volume":"5","author":"KK Roy","year":"2012","unstructured":"Roy KK, Baruah J, Singla S, Sharma JB, Singh N, Jain SK et al (2012) A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reproductive Sci 5(1):20","journal-title":"J Hum Reproductive Sci"},{"key":"10709_CR59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10815-019-01662-z","volume":"37","author":"T Abe","year":"2020","unstructured":"Abe T, Yabuuchi A, Ezoe K, Skaletsky H, Fukuda J, Ueno S et al (2020) Success rates in minimal stimulation cycle IVF with clomiphene citrate only. J Assist Reprod Genet 37:297\u2013304","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"10709_CR60","first-page":"383","volume":"25","author":"VY Tokgoz","year":"2021","unstructured":"Tokgoz VY, Sukur YE, Ozmen B, Sonmezer M, Berker B, Aytac R et al (2021) Clomiphene citrate versus Recombinant FSH in intrauterine insemination cycles with mono-or bi-follicular development. JBRA Assist Reprod 25(3):383","journal-title":"JBRA Assist Reprod"},{"issue":"11","key":"10709_CR61","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4236\/ojog.2019.911149","volume":"9","author":"MA Ibrahem","year":"2019","unstructured":"Ibrahem MA (2019) Simultaneous letrozole and clomiphene citrate versus letrozole alone in clomiphene citrate resistant polycystic ovary syndrome: a randomised controlled trial. Open J Obstet Gynecol 9(11):1532","journal-title":"Open J Obstet Gynecol"},{"issue":"1","key":"10709_CR62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/AOG.0000000000002418","volume":"131","author":"T Jones","year":"2018","unstructured":"Jones T, Ho JR, Gualtieri M, Bruno-Gaston J, Chung K, Paulson RJ et al (2018) Clomiphene stair-step protocol for women with polycystic ovary syndrome. Obstet Gynecol 131(1):91\u201395","journal-title":"Obstet Gynecol"},{"key":"10709_CR63","doi-asserted-by":"crossref","unstructured":"Ajdary M, Keyhanfar F, Aflatoonian R, Amani A, Amjadi F, Zandieh Z et al (2020) Design and evaluation of a novel nanodrug delivery system for reducing the side effects of clomiphene citrate on endometrium. 28:423\u2013432","DOI":"10.1007\/s40199-019-00310-2"},{"key":"10709_CR64","doi-asserted-by":"crossref","unstructured":"Acharya B, Behera A, Behera S, Moharana SJAABM (2024) Recent advances in nanotechnology-based drug delivery systems for the diagnosis and treatment of reproductive disorders. 7(3):1336\u20131361","DOI":"10.1021\/acsabm.3c01064"},{"issue":"4","key":"10709_CR65","first-page":"566","volume":"10","author":"B Bhardwaj","year":"2020","unstructured":"Bhardwaj B, Singh P, Kumar A, Kumar S (2020) Budhwar VJApb. Eco-friendly Greener Synthesis Nanopart 10(4):566","journal-title":"Eco-friendly Greener Synthesis Nanopart"},{"key":"10709_CR66","doi-asserted-by":"crossref","unstructured":"Seth R, Meena AJCT, Policy E (2024) Enzymes-based nanomaterial synthesis: an eco-friendly and green synthesis approach.:1\u201324","DOI":"10.1007\/s10098-024-02854-7"},{"key":"10709_CR67","doi-asserted-by":"crossref","unstructured":"Alsaiari NS, Alzahrani FM, Amari A, Osman H, Harharah HN, Elboughdiri N et al (2023) Plant and microbial approaches as green methods for the synthesis of nanomaterials: synthesis, applications, and future perspectives. 28(1):463","DOI":"10.3390\/molecules28010463"},{"issue":"6","key":"10709_CR68","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/plants10061238","volume":"10","author":"A Kyriakoudi","year":"2021","unstructured":"Kyriakoudi A, Spanidi E, Mourtzinos I, Gardikis K (2021) Innovative delivery systems loaded with plant bioactive ingredients: formulation approaches and applications. Plants 10(6):1238","journal-title":"Plants"},{"issue":"2","key":"10709_CR69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/gels8020097","volume":"8","author":"RK Sindhu","year":"2022","unstructured":"Sindhu RK, Gupta R, Wadhera G, Kumar P (2022) Modern herbal nanogels: formulation, delivery methods, and applications. Gels 8(2):97","journal-title":"Gels"},{"issue":"5","key":"10709_CR70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/pharmaceutics14051091","volume":"14","author":"S Kumari","year":"2022","unstructured":"Kumari S, Goyal A, S\u00f6nmez G\u00fcrer E, Alg\u0131n Yapar E, Garg M, Sood M et al (2022) Bioactive loaded novel nano-formulations for targeted drug delivery and their therapeutic potential. Pharmaceutics 14(5):1091","journal-title":"Pharmaceutics"},{"issue":"1","key":"10709_CR71","first-page":"35","volume":"5","author":"R Kumar","year":"2018","unstructured":"Kumar R, Sharma M (2018) Herbal nanomedicine interactions to enhance pharmacokinetics, pharmacodynamics, and therapeutic index for better bioavailability and biocompatibility of herbal formulations. Mater Nanosci 5(1):35\u201360","journal-title":"Mater Nanosci"},{"key":"10709_CR72","doi-asserted-by":"crossref","unstructured":"Mughees M, Wajid S (2021) Herbal based polymeric nanoparticles as a therapeutic remedy for breast cancer. Anti-Cancer agents in medicinal chemistry (Formerly current medicinal chemistry-Anti-Cancer agents). 21(4):433\u2013444","DOI":"10.2174\/1871520620666200619171616"},{"key":"10709_CR73","doi-asserted-by":"crossref","unstructured":"Ghagane SC, Toragall MM, Akbar AA, Hiremath MBJJHRS (2022) Effect of aloe vera (barbadensis mill) on letrozole induced polycystic ovarian syndrome in Swiss albino mice. 15(2):126\u2013132","DOI":"10.4103\/jhrs.jhrs_22_22"},{"issue":"2","key":"10709_CR74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/jhrs.jhrs_22_22","volume":"15","author":"SC Ghagane","year":"2022","unstructured":"Ghagane SC, Toragall MM, Akbar AA, Hiremath MB (2022) Effect of aloe vera (barbadensis mill) on letrozole induced polycystic ovarian syndrome in Swiss albino mice. J Hum Reproductive Sci 15(2):126\u2013132","journal-title":"J Hum Reproductive Sci"},{"key":"10709_CR75","doi-asserted-by":"crossref","unstructured":"Shen W, Qu Y, Jiang H, Wang H, Pan Y, Zhang Y et al (2022) Therapeutic effect and safety of Curcumin in women with PCOS: A systematic review and meta-analysis. 13:1051111","DOI":"10.3389\/fendo.2022.1051111"},{"key":"10709_CR76","doi-asserted-by":"crossref","unstructured":"Aliakbari F, Mirsadeghi MN, Hashemi E, Rahimi-Madiseh M, Mohammadi BJABR (2022) Effects of combination therapy with Bunium persicum and Foeniculum vulgare extracts on patients with polycystic ovary syndrome. 11(1):74","DOI":"10.4103\/abr.abr_163_21"},{"issue":"1","key":"10709_CR77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/bmc-2020-0005","volume":"11","author":"F Ashkar","year":"2020","unstructured":"Ashkar F, Rezaei S, Salahshoornezhad S, Vahid F, Gholamalizadeh M, Dahka SM et al (2020) The role of medicinal herbs in treatment of insulin resistance in patients with polycystic ovary syndrome: A literature review. Biomol Concepts 11(1):57\u201375","journal-title":"Biomol Concepts"},{"key":"10709_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01865-z","volume":"22","author":"RI Amer","year":"2021","unstructured":"Amer RI, Yassin GE, Mohamed RA, Fayez AM (2021) Pharmaceutical and Pharmacological evaluation of the effect of nano-formulated spironolactone and progesterone on inflammation and hormonal levels for managing hirsutism experimentally induced in rats. AAPS PharmSciTech 22:1\u201311","journal-title":"AAPS PharmSciTech"},{"key":"10709_CR79","doi-asserted-by":"crossref","first-page":"S1574","DOI":"10.1016\/j.arabjc.2012.04.011","volume":"9","author":"MA Rather","year":"2016","unstructured":"Rather MA, Dar BA, Sofi SN, Bhat BA, Qurishi MA (2016) Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety. Arab J Chem 9:S1574\u2013S83","journal-title":"Arab J Chem"},{"issue":"13","key":"10709_CR80","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","volume":"41","author":"RA Sharma","year":"2005","unstructured":"Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so Far. Eur J Cancer 41(13):1955\u20131968","journal-title":"Eur J Cancer"},{"key":"10709_CR81","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40199-019-00312-0","volume":"27","author":"A Moini Jazani","year":"2019","unstructured":"Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Nasimi Doost Azgomi R (2019) A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). DARU J Pharm Sci 27:863\u2013877","journal-title":"DARU J Pharm Sci"},{"issue":"4","key":"10709_CR82","first-page":"83","volume":"8","author":"K Yadav","year":"2020","unstructured":"Yadav K, Ghadge P, Langeh A, Kalbhare S, Phadtare P, Bhoite R (2020) A review on herbal medicinal plant for treatment of polycystic ovarian syndrome (PCOS). Asian J Pharm Res Dev 8(4):83\u201387","journal-title":"Asian J Pharm Res Dev"},{"issue":"10","key":"10709_CR83","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/a-0863-4355","volume":"69","author":"W Arozal","year":"2019","unstructured":"Arozal W, Ramadanty WT, Louisa M, Satyana RPU, Hartono G, Fatrin S et al (2019) Pharmacokinetic profile of Curcumin and Nanocurcumin in plasma, ovary, and other tissues. Drug Res 69(10):559\u2013564","journal-title":"Drug Res"},{"issue":"11","key":"10709_CR84","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.fct.2011.08.006","volume":"49","author":"V Kakkar","year":"2011","unstructured":"Kakkar V, Kaur IP (2011) Evaluating potential of Curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 49(11):2906\u20132913","journal-title":"Food Chem Toxicol"},{"issue":"3\u20134","key":"10709_CR85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2009.02.019","volume":"37","author":"J Shaikh","year":"2009","unstructured":"Shaikh J, Ankola D, Beniwal V, Singh D, Kumar MR (2009) Nanoparticle encapsulation improves oral bioavailability of Curcumin by at least 9-fold when compared to Curcumin administered with Piperine as absorption enhancer. Eur J Pharm Sci 37(3\u20134):223\u2013230","journal-title":"Eur J Pharm Sci"},{"key":"10709_CR86","doi-asserted-by":"crossref","first-page":"118003","DOI":"10.1016\/j.lfs.2020.118003","volume":"256","author":"NZ Abuelezz","year":"2020","unstructured":"Abuelezz NZ, Shabana ME, Abdel-Mageed HM, Rashed L, Morcos GN (2020) Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: insights on PI3K\/AkT\/mTOR and TNF-\u03b1 modulations. Life Sci 256:118003","journal-title":"Life Sci"},{"issue":"1","key":"10709_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42269-019-0164-0","volume":"43","author":"W Gouda","year":"2019","unstructured":"Gouda W, Hafiz NA, Mageed L, Alazzouni AS, Khalil WK, Afify M et al (2019) Effects of nano-curcumin on gene expression of insulin and insulin receptor. Bull Natl Res Centre 43(1):1\u201310","journal-title":"Bull Natl Res Centre"},{"key":"10709_CR88","doi-asserted-by":"crossref","unstructured":"Abuelezz NZ, Shabana ME, Abdel-Mageed HM, Rashed L, Morcos, GNJLs (2020) Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: insights on PI3K\/AkT\/mTOR and TNF-\u03b1 modulations. 256:118003","DOI":"10.1016\/j.lfs.2020.118003"},{"key":"10709_CR89","doi-asserted-by":"crossref","unstructured":"Helli B, Gerami H, Kavianpour M, Heybar H, Hosseini SK (2019) Curcumin nanomicelle versus Curcumin improves lipid profile, stress oxidative factors and inflammatory markers in patients undergoing coronary elective angioplasty; A randomized clinical trial","DOI":"10.21203\/rs.2.18679\/v1"},{"key":"10709_CR90","doi-asserted-by":"crossref","unstructured":"Abuelezz NZ, Shabana E, Rashed M, NB Morcos L (2021) G. Nanocurcumin modulates miR-223-3p and NF-\u03baB levels in the pancreas of rat model of polycystic ovary syndrome to attenuate autophagy flare, insulin resistance and improve \u00df cell mass. J Experimental Pharmacol.:873\u2013888","DOI":"10.2147\/JEP.S323962"},{"key":"10709_CR91","doi-asserted-by":"crossref","unstructured":"Abuelezz NZ, Shabana E, Rashed M, L, NB Morcos GJJoEP (2021). Nanocurcumin modulates miR-223-3p and NF-\u03baB levels in the pancreas of rat model of polycystic ovary syndrome to attenuate autophagy flare, insulin resistance and improve \u00df cell mass.:873\u2013888","DOI":"10.2147\/JEP.S323962"},{"issue":"18","key":"10709_CR92","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.21037\/atm-21-1288","volume":"9","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang Y, Zhao H, Yang Z, Kang Y (2021) Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation. Annals Translational Med 9(18):1405","journal-title":"Annals Translational Med"},{"issue":"1","key":"10709_CR93","first-page":"55","volume":"24","author":"F Zare Bidaki","year":"2021","unstructured":"Zare Bidaki F, Chaichian S, Arbabi Bidgoli S (2021) The role of oral Curcumin nanomicell on improvement of menstrual disorders, depression and anxiety in women with polycystic ovarian syndrome. Iran J Obstet Gynecol Infertility 24(1):55\u201366","journal-title":"Iran J Obstet Gynecol Infertility"},{"issue":"7","key":"10709_CR94","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/ptr.7109","volume":"35","author":"Z Bateni","year":"2021","unstructured":"Bateni Z, Rahimi HR, Hedayati M, Afsharian S, Goudarzi R, Sohrab G (2021) The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double\u2010blind clinical trial. Phytother Res 35(7):3945\u20133953","journal-title":"Phytother Res"},{"key":"10709_CR95","doi-asserted-by":"crossref","first-page":"117515","DOI":"10.1016\/j.lfs.2020.117515","volume":"249","author":"SMF Abhari","year":"2020","unstructured":"Abhari SMF, Khanbabaei R, Roodbari NH, Parivar K, Yaghmaei P (2020) Curcumin-loaded super-paramagnetic iron oxide nanoparticle affects on apoptotic factors expression and histological changes in a prepubertal mouse model of polycystic ovary syndrome-induced by dehydroepiandrosterone-A molecular and Stereological study. Life Sci 249:117515","journal-title":"Life Sci"},{"issue":"17","key":"10709_CR96","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P (2021) Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci 22(17):9652","journal-title":"Int J Mol Sci"},{"key":"10709_CR97","doi-asserted-by":"crossref","unstructured":"Khalaf EM, Abood NA, Atta RZ, Ram\u00edrez-Coronel AA, Alazragi R, Parra RMR et al (2023) Recent progressions in biomedical and pharmaceutical applications of Chitosan nanoparticles: A comprehensive review. Int J Biol Macromol.:123354","DOI":"10.1016\/j.ijbiomac.2023.123354"},{"issue":"2","key":"10709_CR98","doi-asserted-by":"crossref","first-page":"195","DOI":"10.15171\/apb.2019.023","volume":"9","author":"U Garg","year":"2019","unstructured":"Garg U, Chauhan S, Nagaich U, Jain N (2019) Current advances in Chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull 9(2):195","journal-title":"Adv Pharm Bull"},{"key":"10709_CR99","doi-asserted-by":"crossref","unstructured":"Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M (2022) Drug release study of the chitosan-based nanoparticles. Heliyon","DOI":"10.1016\/j.heliyon.2021.e08674"},{"key":"10709_CR100","doi-asserted-by":"crossref","unstructured":"Raja MA, Maldonado M, Chen J, Zhong Y, Gu J (2021) Development and evaluation of Curcumin encapsulated self-assembled nanoparticles as potential remedial treatment for PCOS in a female rat model. Int J Nanomed.:6231\u20136247","DOI":"10.2147\/IJN.S302161"},{"key":"10709_CR101","doi-asserted-by":"crossref","first-page":"111351","DOI":"10.1016\/j.msec.2020.111351","volume":"117","author":"A Bayrami","year":"2020","unstructured":"Bayrami A, Shirdel A, Pouran SR, Mahmoudi F, Habibi-Yangjeh A, Singh R et al (2020) Co-regulative effects of chitosan-fennel seed extract system on the hormonal and biochemical factors involved in the polycystic ovarian syndrome. Mater Sci Engineering: C 117:111351","journal-title":"Mater Sci Engineering: C"},{"key":"10709_CR102","doi-asserted-by":"crossref","unstructured":"Butt MA, Shafique HM, Mustafa M, Moghul NB, Munir A, Shamas U et al (2023) Therapeutic potential of selenium nanoparticles on Letrozole-Induced polycystic ovarian syndrome in female Wistar rats. Biol Trace Elem Res.:1\u201317","DOI":"10.1007\/s12011-023-03579-2"},{"issue":"1\u20132","key":"10709_CR103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1504\/IJBNN.2020.107184","volume":"4","author":"MA Butt","year":"2020","unstructured":"Butt MA, Ullah A, Kiyani MM, Jahan S (2020) Ameliorative effects of selenium nanoparticles on letrozole induced polycystic ovarian syndrome in adult rats. Int J Biomedical Nanosci Nanatechnol 4(1\u20132):49\u201369","journal-title":"Int J Biomedical Nanosci Nanatechnol"},{"key":"10709_CR104","doi-asserted-by":"crossref","first-page":"102217","DOI":"10.1016\/j.bcab.2021.102217","volume":"38","author":"SH Alwan","year":"2021","unstructured":"Alwan SH, Al-Saeed MH (2021) Biosynthesized silver nanoparticles (using Cinnamomum zeylanicum bark extract) improve the fertility status of rats with polycystic ovarian syndrome. Biocatal Agric Biotechnol 38:102217","journal-title":"Biocatal Agric Biotechnol"},{"key":"10709_CR105","doi-asserted-by":"crossref","unstructured":"Al-Bayati MN, Hussein FF, Al-Ahmed HIJJBRC (2024) The effect of silver nanoparticles prepared from the aqueous extract of the Fenugreek plant on some of the hormones associated with polycystic ovary syndrome in female laboratory rats. 18(2):84\u201393","DOI":"10.24126\/jobrc.2024.18.2.787"},{"key":"10709_CR106","doi-asserted-by":"crossref","unstructured":"Alwan SH, Al-Saeed MHJB, Biotechnology A (2021) Biosynthesized silver nanoparticles (using Cinnamomum zeylanicum bark extract) improve the fertility status of rats with polycystic ovarian syndrome. 38:102217","DOI":"10.1016\/j.bcab.2021.102217"},{"issue":"4","key":"10709_CR107","first-page":"229","volume":"3","author":"E Salami","year":"2018","unstructured":"Salami E, Karami M, Jafaryan Dehkordi A, Jalali Nadoushan M, Hajnorouzi A (2018) Protective effect of silver nano particles against ovarian polycystic induced by morphine in rat. Nanomed Res J 3(4):229\u2013235","journal-title":"Nanomed Res J"},{"key":"10709_CR108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ, Exosomes (2019) Annu Rev Biochem 88:487\u2013514","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"10709_CR109","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","volume":"1820","author":"AV Vlassov","year":"2012","unstructured":"Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Et Biophys Acta (BBA)-General Subj 1820(7):940\u2013948","journal-title":"Biochim Et Biophys Acta (BBA)-General Subj"},{"issue":"6478","key":"10709_CR110","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977","journal-title":"Science"},{"issue":"2","key":"10709_CR111","doi-asserted-by":"crossref","first-page":"1802896","DOI":"10.1002\/adma.201802896","volume":"31","author":"B Yang","year":"2019","unstructured":"Yang B, Chen Y, Shi J (2019) Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Adv Mater 31(2):1802896","journal-title":"Adv Mater"},{"issue":"4","key":"10709_CR112","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/ijms22042165","volume":"22","author":"S Esfandyari","year":"2021","unstructured":"Esfandyari S, Elkafas H, Chugh RM, Park H-s, Navarro A, Al-Hendy A (2021) Exosomes as biomarkers for female reproductive diseases diagnosis and therapy. Int J Mol Sci 22(4):2165","journal-title":"Int J Mol Sci"},{"key":"10709_CR113","doi-asserted-by":"crossref","unstructured":"Rezaie J, Feghhi M, Etemadi TJCC (2022) Signaling. A review on exosomes application in clinical trials: perspective, questions, and challenges. 20(1):145","DOI":"10.1186\/s12964-022-00959-4"},{"key":"10709_CR114","doi-asserted-by":"crossref","unstructured":"Zhao Y, Pan S, Li Y, Wu XJS (2022) Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome. 12(1):4359","DOI":"10.1038\/s41598-022-08423-6"},{"issue":"1","key":"10709_CR115","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41598-022-08423-6","volume":"12","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Pan S, Li Y, Wu X (2022) Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome. Sci Rep 12(1):4359","journal-title":"Sci Rep"},{"issue":"4","key":"10709_CR116","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s12035-021-02714-1","volume":"59","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Tu Z, Zhang J, Tan C, Shen X, Wan B et al (2022) Follicular fluid-derived Exosomal MicroRNA-18b-5p regulates PTEN-Mediated PI3K\/Akt\/mTOR signaling pathway to inhibit polycystic ovary syndrome development. Mol Neurobiol 59(4):2520\u20132531","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10709_CR117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12958-021-00749-6","volume":"19","author":"L Yu","year":"2021","unstructured":"Yu L, Liu M, Wang Z, Liu T, Liu S, Wang B et al (2021) Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome. Reproductive Biology Endocrinol 19(1):74","journal-title":"Reproductive Biology Endocrinol"},{"key":"10709_CR118","doi-asserted-by":"crossref","first-page":"105315","DOI":"10.1016\/j.chemphyslip.2023.105315","volume":"255","author":"A Raj","year":"2023","unstructured":"Raj A, Dua K, Nair RS, Chandran CS, Alex AT (2023) Transethosome: an ultra-deformable ethanolic vesicle for enhanced transdermal drug delivery. Chem Phys Lipids 255:105315","journal-title":"Chem Phys Lipids"},{"issue":"04","key":"10709_CR119","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/a-1974-9078","volume":"73","author":"M Adnan","year":"2023","unstructured":"Adnan M, Haider MF, Naseem N, Haider T (2023) Transethosomes: a promising challenge for topical delivery short title: transethosomes for topical delivery. Drug Res 73(04):200\u2013212","journal-title":"Drug Res"},{"key":"10709_CR120","doi-asserted-by":"crossref","unstructured":"Munir M, Zaman M, Waqar MA, Hameed H, Riaz TJJLR (2024) A comprehensive review on transethosomes as a novel vesicular approach for drug delivery through transdermal route. 34(1):203\u2013218","DOI":"10.1080\/08982104.2023.2221354"},{"key":"10709_CR121","doi-asserted-by":"crossref","unstructured":"Albash R, Abdelbary AA, Refai H, El-Nabarawi, MAJIjon (2019) Use of transethosomes for enhancing the transdermal delivery of Olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.:1953\u20131968","DOI":"10.2147\/IJN.S196771"},{"key":"10709_CR122","doi-asserted-by":"crossref","unstructured":"Salem HF, Kharshoum RM, Abou-Taleb HA, AbouTaleb HA, AbouElhassan KMJJ (2019) Progesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome. 29(2):183\u2013194","DOI":"10.1080\/08982104.2018.1524483"},{"key":"10709_CR123","first-page":"33","volume":"2","author":"KK Mishra","year":"2019","unstructured":"Mishra KK, Kaur CD, Verma S, Sahu AK, Dash DK, Kashyap P et al (2019) Transethosomes and nanoethosomes: recent approach on transdermal drug delivery system. Nanomedicine 2:33\u201354","journal-title":"Nanomedicine"},{"key":"10709_CR124","doi-asserted-by":"crossref","unstructured":"Bin Jardan YA, Ahad A, Raish M, Al-Jenoobi FIJP (2023) Preparation and characterization of transethosome formulation for the enhanced delivery of sinapic acid. 15(10):2391","DOI":"10.3390\/pharmaceutics15102391"},{"issue":"2","key":"10709_CR125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08982104.2018.1524483","volume":"29","author":"HF Salem","year":"2019","unstructured":"Salem HF, Kharshoum RM, Abou-Taleb HA, AbouTaleb HA, AbouElhassan KM (2019) Progesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome. J Liposome Res 29(2):183\u2013194","journal-title":"J Liposome Res"},{"key":"10709_CR126","unstructured":"Karami M, Salami E, Dehkordi AJ, Nadoushan MJ, Hajnorouzi A (2018) Protective effect of silver nano particles against ovarian polycystic induced by morphine in rat. Nanomed Res J.;3(4)"},{"key":"10709_CR127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bios.2014.08.043","volume":"64","author":"H Fan","year":"2015","unstructured":"Fan H, Guo Z, Gao L, Zhang Y, Fan D, Ji G et al (2015) Ultrasensitive electrochemical immunosensor for carbohydrate antigen 72\u2013\u20094 based on dual signal amplification strategy of nanoporous gold and polyaniline\u2013Au asymmetric multicomponent nanoparticles. Biosens Bioelectron 64:51\u201356","journal-title":"Biosens Bioelectron"},{"key":"10709_CR128","doi-asserted-by":"crossref","first-page":"110030","DOI":"10.1016\/j.cellsig.2021.110030","volume":"85","author":"D Yuan","year":"2021","unstructured":"Yuan D, Luo J, Sun Y, Hao L, Zheng J, Yang Z (2021) PCOS follicular fluid derived Exosomal miR-424-5p induces granulosa cells senescence by targeting CDCA4 expression. Cell Signal 85:110030","journal-title":"Cell Signal"},{"issue":"3","key":"10709_CR129","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.fertnstert.2020.08.019","volume":"115","author":"X Jiang","year":"2021","unstructured":"Jiang X, Li J, Zhang B, Hu J, Ma J, Cui L et al (2021) Differential expression profile of plasma Exosomal MicroRNAs in women with polycystic ovary syndrome. Fertil Steril 115(3):782\u2013792","journal-title":"Fertil Steril"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10709-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10709-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10709-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:31:23Z","timestamp":1766853083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10709-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10709"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10709-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate declarations"}}],"article-number":"618"}}